Brimonidine Beyond a Single Specialty: Pharmacological Profile, Dermatologic Applications, and Advances in Drug Delivery Systems

Brimonidine, initially used for glaucoma, is effective in dermatology for treating facial erythema in rosacea due to its vasoconstrictive and anti-inflammatory properties. It also shows promise in managing alcohol flushing syndrome and post-procedural erythema. Despite its benefits, challenges like rebound erythema and limited long-term data exist. Advances in drug delivery systems, such as nanotechnology, aim to enhance its efficacy and safety, though further clinical trials are needed. The review highlights the potential for broader applications and the importance of interdisciplinary innovation in pharmacology and formulation science to optimize brimonidine's therapeutic use in dermatology.